Pedia-lax Tablet, Chewable
NDC Package 0132-0655-01
Package Information
Pedia-lax (magnesium hydroxide) tablets is a medication used for a short time to treat occasional constipation. This formulation utilizes a tablet, chewable delivery system. Marketed by C.b. Fleet Company, Inc., this product is identified by NDC 0132-0655 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 1088243 - Pedia-Lax Chewable 400 MG Chewable Tablet
- RxCUI: 1088243 - magnesium hydroxide 400 MG Chewable Tablet [Pedia-Lax Chewable]
- RxCUI: 790436 - magnesium hydroxide 400 MG Chewable Tablet
- RxCUI: 790436 - milk of magnesia 400 MG Chewable Tablet
Clinical Specifications
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 0132 - C.b. Fleet Company, Inc.
- 0132-0655 - Pedia-lax
- 0132-0655-01 - 1 BOTTLE in 1 CARTON / 30 TABLET, CHEWABLE in 1 BOTTLE
- 0132-0655 - Pedia-lax
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0132-0655-01 identifies a specific commercial package of 1 bottle in 1 carton / 30 tablet, chewable in 1 bottle of Pedia-lax, a human over the counter drug labeled by C.b. Fleet Company, Inc.. This tablet, chewable is formulated for oral use and contains magnesium hydroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by C.b. Fleet Company, Inc. on March 01, 2008. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used for a short time to treat occasional constipation. It is a laxative (osmotic-type) that is thought to work by drawing water into the intestines, an effect that helps to cause movement of the intestines. This medication is also used to treat symptoms caused by too much stomach acid such as heartburn, upset stomach, or indigestion. It is an antacid that works by lowering the amount of acid in the stomach.
How is this C.b. Fleet Company, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00132065501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.